1. Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation
   WEI-YU HU et al, 2014 CrossRef
2. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
   Do Seon Song et al, 2015, J Gastroenterol CrossRef
3. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting
   Masaaki Kondo et al, 2015, Journal of Digestive Diseases CrossRef
4. Current management of hepatocellular carcinoma: An Eastern perspective
   Hyung Joon Yim, 2015, WJG CrossRef
5. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series
   TOMOYUKI NEMOTO et al, 2014 CrossRef
6. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma
   Min Kyu Kang et al, 2018, Medicine CrossRef
7. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
   Jong Hwan Choi et al, 2018, Cancer Chemother Pharmacol CrossRef
8. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
   Takamasa Ohki et al, 2017, Adv Ther CrossRef
9. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
   Reina Sasaki et al, 2019, IJMS CrossRef
10. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Bo-wen Zhuang et al, 2019 CrossRef
11. Efficacy and optimal treatment sequence of Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Yasunari Hiramine et al, 2013, Kanzo CrossRef
12. Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
    Kotaro Fukubayashi et al, 2015, Cancer Med CrossRef
13. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
    Hyun Young Woo et al, 2015, Clin Mol Hepatol CrossRef
14. Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
    Sun Hong Yoo et al, 2020, Cancer Control CrossRef
15. The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Shengzhou Li et al, 2021, Chemotherapy CrossRef
16. Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization
    Chao An et al, 2023, Academic Radiology CrossRef
17. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis
    Shun-An Zhou et al, 2024, World J Gastrointest Oncol CrossRef
18. Optimal candidates and surrogate endpoints for HAIC versus Sorafenib in hepatocellular carcinoma: an updated systematic review and meta-analysis
    Tengfei Si et al, 2025 CrossRef